1,2-Bis(2-iodoethoxy)ethane CAS: 36839-55-1: A Key PEG-Based PROTAC Linker for Drug Discovery
Unlock novel therapeutic pathways with 1,2-Bis(2-iodoethoxy)ethane, a critical component in the synthesis of next-generation PROTACs. Discover its role in targeted protein degradation and advanced chemical synthesis from a leading supplier.
Get a Quote & SampleProduct Core Value

1,2-Bis(2-iodoethoxy)ethane
As a premier supplier in China, we provide high-quality 1,2-Bis(2-iodoethoxy)ethane, a vital PEG-based PROTAC linker. This compound is instrumental in the synthesis of advanced molecules for targeted protein degradation, a rapidly growing field in drug discovery. Its reliability and purity make it a preferred choice for researchers and pharmaceutical manufacturers.
- Discover the advantages of using a reliable PROTAC linker synthesis partner in China for your drug development projects.
- Leverage the power of PEG-based PROTAC linker technology to enhance the efficacy and specificity of your therapeutic candidates.
- Explore the synthesis of potent BTK degraders and other targeted protein degraders with our high-purity chemical intermediates.
- Understand the critical chemical properties of 1,2-Bis(2-iodoethoxy)ethane, essential for successful experimental design and outcomes.
Product Advantages
High Purity for Reliable Synthesis
Achieve consistent and reproducible results in your PROTAC synthesis with our 1,2-Bis(2-iodoethoxy)ethane, ensuring a purity of 95%min, critical for complex chemical reactions.
Essential for Targeted Protein Degradation
This PEG-based PROTAC linker is fundamental for developing cutting-edge therapies in targeted protein degradation, contributing to advancements in drug discovery.
Stable and Easy to Handle
Our 1,2-Bis(2-iodoethoxy)ethane is a clear red-orange liquid, stable under normal temperatures and pressures, simplifying handling and storage in your laboratory setting.
Key Applications
PROTAC Synthesis
Utilize this compound as a crucial linker in the synthesis of Proteolysis Targeting Chimeras (PROTACs), a revolutionary approach in drug discovery.
Targeted Protein Degradation
Its role as a PEG-based linker is vital for creating molecules that specifically target and degrade disease-causing proteins.
Pharmaceutical Intermediates
Serve as a high-quality intermediate in the broader pharmaceutical industry, enabling the creation of diverse and complex drug molecules.
Chemical Linker Technology
Explore its application in various chemical synthesis endeavors where a robust and versatile linker is required.